CDAM UK Ltd boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 2.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 232,962 shares of the technology company’s stock after purchasing an additional 4,980 shares during the period. Veeva Systems accounts for approximately 9.5% of CDAM UK Ltd’s holdings, making the stock its 5th largest holding. CDAM UK Ltd owned approximately 0.14% of Veeva Systems worth $52,004,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Board of the Pension Protection Fund bought a new position in Veeva Systems in the 4th quarter valued at $27,000. Raiffeisen Bank International AG bought a new position in Veeva Systems in the 3rd quarter valued at $28,000. Newbridge Financial Services Group Inc. boosted its position in Veeva Systems by 322.6% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the last quarter. Activest Wealth Management boosted its position in Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 127 shares during the last quarter. Finally, BOK Financial Private Wealth Inc. bought a new position in Veeva Systems in the 4th quarter valued at $33,000. 88.20% of the stock is owned by institutional investors and hedge funds.
Veeva Systems Stock Down 1.3%
NYSE:VEEV opened at $159.44 on Friday. Veeva Systems Inc. has a 12-month low of $148.05 and a 12-month high of $310.50. The firm has a market capitalization of $25.90 billion, a P/E ratio of 28.42, a P/E/G ratio of 0.69 and a beta of 0.95. The stock’s fifty day simple moving average is $165.06 and its 200-day simple moving average is $192.11.
Wall Street Analysts Forecast Growth
VEEV has been the topic of a number of recent research reports. Royal Bank Of Canada reiterated an “outperform” rating and issued a $275.00 price objective on shares of Veeva Systems in a research report on Thursday, June 4th. Stifel Nicolaus decreased their price objective on Veeva Systems from $245.00 to $230.00 and set a “buy” rating on the stock in a research report on Thursday, June 4th. Oppenheimer reiterated an “outperform” rating and issued a $225.00 price objective on shares of Veeva Systems in a research report on Thursday, June 4th. Canaccord Genuity Group decreased their price objective on Veeva Systems from $235.00 to $220.00 and set a “hold” rating on the stock in a research report on Thursday, June 4th. Finally, Mizuho decreased their price objective on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research report on Thursday, June 4th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and an average price target of $250.96.
Get Our Latest Research Report on VEEV
Insider Activity
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the transaction, the director directly owned 3,253 shares in the company, valued at approximately $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
